Literature DB >> 23788657

Selective agonists and antagonists of formylpeptide receptors: duplex flow cytometry and mixture-based positional scanning libraries.

Clemencia Pinilla1, Bruce S Edwards, Jon R Appel, Tina Yates-Gibbins, Marc A Giulianotti, Jose L Medina-Franco, Susan M Young, Radleigh G Santos, Larry A Sklar, Richard A Houghten.   

Abstract

The formylpeptide receptor (FPR1) and formylpeptide-like 1 receptor (FPR2) are G protein-coupled receptors that are linked to acute inflammatory responses, malignant glioma stem cell metastasis, and chronic inflammation. Although several N-formyl peptides are known to bind to these receptors, more selective small-molecule, high-affinity ligands are needed for a better understanding of the physiologic roles played by these receptors. High-throughput assays using mixture-based combinatorial libraries represent a unique, highly efficient approach for rapid data acquisition and ligand identification. We report the superiority of this approach in the context of the simultaneous screening of a diverse set of mixture-based small-molecule libraries. We used a single cross-reactive peptide ligand for a duplex flow cytometric screen of FPR1 and FPR2 in color-coded cell lines. Screening 37 different mixture-based combinatorial libraries totaling more than five million small molecules (contained in 5,261 mixture samples) resulted in seven libraries that significantly inhibited activity at the receptors. Using positional scanning deconvolution, selective high-affinity (low nM K(i)) individual compounds were identified from two separate libraries, namely, pyrrolidine bis-diketopiperazine and polyphenyl urea. The most active individual compounds were characterized for their functional activities as agonists or antagonists with the most potent FPR1 agonist and FPR2 antagonist identified to date with an EC₅₀ of 131 nM (4 nM K(i)) and an IC₅₀ of 81 nM (1 nM K(i)), respectively, in intracellular Ca²⁺ response determinations. Comparative analyses of other previous screening approaches clearly illustrate the efficiency of identifying receptor selective, individual compounds from mixture-based combinatorial libraries.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23788657      PMCID: PMC3876812          DOI: 10.1124/mol.113.086595

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  46 in total

Review 1.  Mixture-based synthetic combinatorial libraries.

Authors:  R A Houghten; C Pinilla; J R Appel; S E Blondelle; C T Dooley; J Eichler; A Nefzi; J M Ostresh
Journal:  J Med Chem       Date:  1999-09-23       Impact factor: 7.446

2.  On outliers and activity cliffs--why QSAR often disappoints.

Authors:  Gerald M Maggiora
Journal:  J Chem Inf Model       Date:  2006 Jul-Aug       Impact factor: 4.956

3.  The interaction of 3,5-pyrazolidinedione drugs with receptors for f-Met-Leu-Phe on human neutrophil leukocytes: a study of the structure-activity relationship.

Authors:  L Levesque; R C Gaudreault; F Marceau
Journal:  Can J Physiol Pharmacol       Date:  1991-03       Impact factor: 2.273

4.  Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors.

Authors:  Stéphane Rivière; Ludivine Challet; Daniela Fluegge; Marc Spehr; Ivan Rodriguez
Journal:  Nature       Date:  2009-05-28       Impact factor: 49.962

5.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.

Authors:  R A Houghten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

6.  The use of positional scanning synthetic peptide combinatorial libraries for the rapid determination of opioid receptor ligands.

Authors:  C T Dooley; R A Houghten
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

7.  "Libraries from libraries": chemical transformation of combinatorial libraries to extend the range and repertoire of chemical diversity.

Authors:  J M Ostresh; G M Husar; S E Blondelle; B Dörner; P A Weber; R A Houghten
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

8.  Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition.

Authors:  Liliya N Kirpotina; Andrei I Khlebnikov; Igor A Schepetkin; Richard D Ye; Marie-Josèphe Rabiet; Mark A Jutila; Mark T Quinn
Journal:  Mol Pharmacol       Date:  2009-11-10       Impact factor: 4.436

Review 9.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

10.  6-methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors.

Authors:  Agostino Cilibrizzi; Mark T Quinn; Liliya N Kirpotina; Igor A Schepetkin; Jeff Holderness; Richard D Ye; Marie-Josephe Rabiet; Claudio Biancalani; Nicoletta Cesari; Alessia Graziano; Claudia Vergelli; Stefano Pieretti; Vittorio Dal Piaz; Maria Paola Giovannoni
Journal:  J Med Chem       Date:  2009-08-27       Impact factor: 7.446

View more
  15 in total

1.  The University of New Mexico Center for Molecular Discovery.

Authors:  Bruce S Edwards; Kristine Gouveia; Tudor I Oprea; Larry A Sklar
Journal:  Comb Chem High Throughput Screen       Date:  2014-03       Impact factor: 1.339

2.  Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.

Authors:  Igor A Schepetkin; Liliya N Kirpotina; Andrei I Khlebnikov; Ni Cheng; Richard D Ye; Mark T Quinn
Journal:  Biochem Pharmacol       Date:  2014-10-17       Impact factor: 5.858

Review 3.  Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition.

Authors:  I A Schepetkin; A I Khlebnikov; M P Giovannoni; L N Kirpotina; A Cilibrizzi; M T Quinn
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

4.  Functional N-Formyl Peptide Receptor 2 (FPR2) Antagonists Based on the Ureidopropanamide Scaffold Have Potential To Protect Against Inflammation-Associated Oxidative Stress.

Authors:  Madia L Stama; Enza Lacivita; Liliya N Kirpotina; Mauro Niso; Roberto Perrone; Igor A Schepetkin; Mark T Quinn; Marcello Leopoldo
Journal:  ChemMedChem       Date:  2017-11-07       Impact factor: 3.466

Review 5.  Flow Cytometry: Impact on Early Drug Discovery.

Authors:  Bruce S Edwards; Larry A Sklar
Journal:  J Biomol Screen       Date:  2015-03-24

6.  SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.

Authors:  Anna M Knapinska; Daniela Dreymuller; Andreas Ludwig; Lyndsay Smith; Vladislav Golubkov; Anjum Sohail; Rafael Fridman; Marc Giulianotti; Travis M LaVoi; Richard A Houghten; Gregg B Fields; Dmitriy Minond
Journal:  J Med Chem       Date:  2015-08-04       Impact factor: 7.446

7.  Rapid scanning structure-activity relationships in combinatorial data sets: identification of activity switches.

Authors:  José L Medina-Franco; Bruce S Edwards; Clemencia Pinilla; Jon R Appel; Marc A Giulianotti; Radleigh G Santos; Austin B Yongye; Larry A Sklar; Richard A Houghten
Journal:  J Chem Inf Model       Date:  2013-06-07       Impact factor: 4.956

8.  Scaffold ranking and positional scanning utilized in the discovery of nAChR-selective compounds suitable for optimization studies.

Authors:  Jinhua Wu; Yaohong Zhang; Laura E Maida; Radleigh G Santos; Gregory S Welmaker; Travis M LaVoi; Adel Nefzi; Yongping Yu; Richard A Houghten; Lawrence Toll; Marc A Giulianotti
Journal:  J Med Chem       Date:  2013-12-12       Impact factor: 7.446

Review 9.  The role of formylated peptides and formyl peptide receptor 1 in governing neutrophil function during acute inflammation.

Authors:  David A Dorward; Christopher D Lucas; Gavin B Chapman; Christopher Haslett; Kevin Dhaliwal; Adriano G Rossi
Journal:  Am J Pathol       Date:  2015-03-17       Impact factor: 4.307

10.  Novel pyrrolidine diketopiperazines selectively inhibit melanoma cells via induction of late-onset apoptosis.

Authors:  Lillian Onwuha-Ekpete; Lisa Tack; Anna Knapinska; Lyndsay Smith; Gaurav Kaushik; Travis Lavoi; Marc Giulianotti; Richard A Houghten; Gregg B Fields; Dmitriy Minond
Journal:  J Med Chem       Date:  2014-02-05       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.